<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:thyp="http://21shareshyperliquidetf.com/20260930"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="thyp-20260930.xsd" xlink:type="simple"/>
    <context id="cref_319941239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_179931627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1474050272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1942895230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thyp:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1638411861">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thyp:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_171125964">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thyp:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thyp:SeedCreationBasketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-11</startDate>
            <endDate>2026-05-11</endDate>
        </period>
    </context>
    <context id="cref_780255807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thyp:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thyp:SeedCreationBasketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-11</instant>
        </period>
    </context>
    <context id="cref_1432048928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thyp:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thyp:InitialSeedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-18</startDate>
            <endDate>2026-03-18</endDate>
        </period>
    </context>
    <context id="cref_2032790478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thyp:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">thyp:InitialSeedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-18</instant>
        </period>
    </context>
    <context id="cref_1938330277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thyp:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_119824875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
        </entity>
        <period>
            <instant>2026-09-29</instant>
        </period>
    </context>
    <context id="cref_596655373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
        </entity>
        <period>
            <startDate>2026-09-29</startDate>
            <endDate>2026-09-29</endDate>
        </period>
    </context>
    <context id="cref_2105076071">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_914890394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_491529723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">thyp:StakingRewardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="cref_1193439043">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">thyp:InvestmentInHYPEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:OfNetAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1694967875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">thyp:InvestmentInHYPEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:FairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_24691696">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:OfNetAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_124896620">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:FairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_2054357979">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:CostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_408845929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:QuantityOfHYPEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_865381281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">thyp:InvestmentInHYPEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:CostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_813332056">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">thyp:InvestmentInHYPEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:QuantityOfHYPEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_352264313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">thyp:InvestmentInHYPEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:OfNetAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1886031040">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">thyp:InvestmentInHYPEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:FairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1884152803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:OfNetAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_649003262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:FairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_446126599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:CostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1921669072">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:QuantityOfHYPEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1526000497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">thyp:InvestmentInHYPEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:CostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_437559600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerAffiliationAxis">thyp:InvestmentInHYPEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentIssuerNameAxis">thyp:QuantityOfHYPEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_847704435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
        </entity>
        <period>
            <instant>2026-11-09</instant>
        </period>
    </context>
    <context id="cref_1004901826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_491627755">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="cref_1876435551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_861537726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="cref_1022023144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-06-30</endDate>
        </period>
    </context>
    <context id="cref_104605228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002090011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">thyp:SeedCapitalInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-18</startDate>
            <endDate>2026-03-18</endDate>
        </period>
    </context>
    <unit id="uref_1489602641">
        <measure>pure</measure>
    </unit>
    <unit id="uref_179931627">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="uref_1042948581">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_1942895230">
        <measure>shares</measure>
    </unit>
    <unit id="uref_1662653229">
        <measure>thyp:Segments</measure>
    </unit>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_1004901826"
      id="fc_1004901826"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_491627755"
      id="fc_491627755"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:Cash
      contextRef="cref_1474050272"
      id="fc_1363118503"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="cref_1474050272"
      id="fc_1343547983"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_1474050272"
      id="fc_1498962365"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_319941239" id="fc_186673792">http://fasb.org/srt/2026#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_1876435551"
      id="fc_1876435551"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_861537726"
      id="fc_861537726"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <thyp:QuantityOfHYPENetRealizedGainOnInvestmentInHYPEDistributedForIn-KindRedemotions
      contextRef="cref_319941239"
      id="fc_1779338889"
      unitRef="uref_1489602641"
      xsi:nil="true"/>
    <us-gaap:CommonStockNoParValue
      contextRef="cref_1474050272"
      id="fc_632264421"
      unitRef="uref_179931627"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="cref_1022023144" id="fc_1022023144">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_104605228"
      decimals="0"
      id="fc_104605228"
      unitRef="uref_1942895230">2</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:PayableInvestmentPurchase
      contextRef="cref_1474050272"
      id="fc_911737347"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:PayableInvestmentPurchase
      contextRef="cref_179931627"
      id="fc_1003635765"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:ReceivableInvestmentSale
      contextRef="cref_179931627"
      id="fc_2105761333"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:CommonStockNoParValue
      contextRef="cref_179931627"
      id="fc_1601540423"
      unitRef="uref_179931627"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="cref_319941239" id="fc_1188611376">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <thyp:CapitalSharesPayable
      contextRef="cref_179931627"
      id="fc_10217626"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_179931627"
      id="fc_2123871420"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <us-gaap:ReceivableInvestmentSale
      contextRef="cref_179931627"
      id="fc_628383808"
      unitRef="uref_1042948581"
      xsi:nil="true"/>
    <thyp:QuantityOfHYPENetRealizedGainOnInvestmentInHYPESoldToPaySponsorFee
      contextRef="cref_319941239"
      id="fc_937087038"
      unitRef="uref_1489602641"
      xsi:nil="true"/>
    <thyp:QuantityOfHYPENetRealizedGainOnInvestmentInHYPESoldForRedemptions
      contextRef="cref_319941239"
      id="fc_1840905536"
      unitRef="uref_1489602641"
      xsi:nil="true"/>
    <thyp:QuantityOfHYPENetRealizedGainOnInvestmentInHYPESoldForDistributions
      contextRef="cref_319941239"
      id="fc_1546356471"
      unitRef="uref_1489602641"
      xsi:nil="true"/>
    <thyp:QuantityOfHYPENetChangeInUnrealizedAppreciationOnInvestmentInHYPE
      contextRef="cref_319941239"
      id="fc_431398733"
      unitRef="uref_1489602641"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="cref_319941239" id="ixv-2901">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_319941239" id="ixv-2902">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="cref_319941239" id="ixv-2903">0002090011</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="cref_319941239" id="ixv-2904">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_319941239" id="ixv-2905">2027</dei:DocumentFiscalYearFocus>
    <dei:DocumentType contextRef="cref_319941239" id="ixv-3208">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="cref_319941239" id="fc_465726698">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="cref_319941239" id="ixv-3210">2026-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="cref_319941239" id="ixv-3211">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_319941239" id="ixv-3212">001-43278</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_319941239" id="ixv-3213">21Shares Hyperliquid Staking ETF</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_319941239" id="ixv-3214">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="cref_319941239" id="ixv-3215">39-7064755</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="cref_319941239" id="ixv-154">158 W. 27th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="cref_319941239" id="ixv-3216">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_319941239" id="ixv-3217">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_319941239" id="ixv-3218">10001</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_319941239" id="ixv-3219">(646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_319941239" id="ixv-3220">370-6016</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_319941239" id="ixv-3221">Shares of Beneficial Interest of 21Shares Hyperliquid Staking ETF</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_319941239" id="ixv-3222">THYP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_319941239" id="ixv-3223">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="cref_319941239" id="ixv-3224">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_319941239" id="ixv-3225">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_319941239" id="ixv-3226">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_319941239" id="ixv-3227">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_319941239" id="ixv-3228">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_319941239" id="ixv-3229">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="cref_319941239" id="ixv-3230">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_847704435"
      decimals="0"
      id="ixv-3231"
      unitRef="uref_1942895230">1120000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="cref_179931627"
      decimals="0"
      id="ixv-3232"
      unitRef="uref_1042948581">59998967</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="cref_1474050272"
      decimals="0"
      id="ixv-3233"
      unitRef="uref_1042948581">58533802</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_179931627"
      decimals="0"
      id="fc_1575666155"
      unitRef="uref_1042948581">90783674</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_1474050272"
      decimals="0"
      id="ixv-3235"
      unitRef="uref_1042948581">71177725</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:ReceivableInvestmentSale
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_1461453783"
      unitRef="uref_1042948581">3010519</us-gaap:ReceivableInvestmentSale>
    <us-gaap:Cash
      contextRef="cref_179931627"
      decimals="0"
      id="ixv-3237"
      unitRef="uref_1042948581">338707</us-gaap:Cash>
    <us-gaap:Assets
      contextRef="cref_179931627"
      decimals="0"
      id="fc_1428622980"
      unitRef="uref_1042948581">91122381</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_1481929306"
      unitRef="uref_1042948581">74188244</us-gaap:Assets>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="cref_179931627"
      decimals="0"
      id="ixv-3240"
      unitRef="uref_1042948581">338707</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <thyp:CapitalSharesPayable
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_1760575494"
      unitRef="uref_1042948581">3010519</thyp:CapitalSharesPayable>
    <thyp:SponsorFeePayable
      contextRef="cref_179931627"
      decimals="0"
      id="fc_2133023586"
      unitRef="uref_1042948581">2004</thyp:SponsorFeePayable>
    <thyp:SponsorFeePayable
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_1462045728"
      unitRef="uref_1042948581">2736</thyp:SponsorFeePayable>
    <us-gaap:Liabilities
      contextRef="cref_179931627"
      decimals="0"
      id="fc_1111766225"
      unitRef="uref_1042948581">340711</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_1560774275"
      unitRef="uref_1042948581">3013255</us-gaap:Liabilities>
    <us-gaap:AssetsNet
      contextRef="cref_179931627"
      decimals="0"
      id="fc_1812809621"
      unitRef="uref_1042948581">90781670</us-gaap:AssetsNet>
    <us-gaap:AssetsNet
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_676793574"
      unitRef="uref_1042948581">71174989</us-gaap:AssetsNet>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_179931627"
      decimals="0"
      id="fc_1329776751"
      unitRef="uref_1042948581">55598932</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_2037707198"
      unitRef="uref_1042948581">57741756</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_179931627"
      decimals="0"
      id="fc_613689962"
      unitRef="uref_1042948581">35182738</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_470412845"
      unitRef="uref_1042948581">13433233</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_179931627"
      decimals="0"
      id="fc_1788369497"
      unitRef="uref_1042948581">90781670</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_1212029113"
      unitRef="uref_1042948581">71174989</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_179931627"
      decimals="0"
      id="fc_1929308293"
      unitRef="uref_1942895230">1770000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_606150739"
      unitRef="uref_1942895230">1880000</us-gaap:CommonStockSharesIssued>
    <us-gaap:NetAssetValuePerShare
      contextRef="cref_179931627"
      decimals="2"
      id="fc_1125134374"
      unitRef="uref_179931627">51.29</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="cref_1474050272"
      decimals="2"
      id="fc_1628503737"
      unitRef="uref_179931627">37.86</us-gaap:NetAssetValuePerShare>
    <us-gaap:InvestmentOwnedBalanceContracts
      contextRef="cref_437559600"
      decimals="4"
      id="fc_437559600"
      unitRef="uref_1489602641">1023491.253</us-gaap:InvestmentOwnedBalanceContracts>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="cref_1526000497"
      decimals="0"
      id="fc_1526000497"
      unitRef="uref_1042948581">59998967</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_1886031040"
      decimals="0"
      id="fc_1765843386"
      unitRef="uref_1042948581">90783674</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="cref_352264313"
      decimals="4"
      id="fc_789196709"
      unitRef="uref_1489602641">1</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceContracts
      contextRef="cref_1921669072"
      decimals="4"
      id="ixv-3262"
      unitRef="uref_1489602641">1023491.253</us-gaap:InvestmentOwnedBalanceContracts>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="cref_446126599"
      decimals="0"
      id="ixv-3263"
      unitRef="uref_1042948581">59998967</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_649003262"
      decimals="0"
      id="fc_649003262"
      unitRef="uref_1042948581">90783674</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="cref_1884152803"
      decimals="4"
      id="fc_1884152803"
      unitRef="uref_1489602641">1</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities
      contextRef="cref_1886031040"
      decimals="0"
      id="ixv-3266"
      unitRef="uref_1042948581">-2004</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets
      contextRef="cref_352264313"
      decimals="4"
      id="fc_1952849613"
      unitRef="uref_1489602641">-0</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets>
    <us-gaap:AssetsNet
      contextRef="cref_1886031040"
      decimals="0"
      id="ixv-3268"
      unitRef="uref_1042948581">90781670</us-gaap:AssetsNet>
    <thyp:PercentageOfNetAssets
      contextRef="cref_352264313"
      decimals="4"
      id="fc_352264313"
      unitRef="uref_1489602641">1</thyp:PercentageOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceContracts
      contextRef="cref_813332056"
      decimals="4"
      id="fc_813332056"
      unitRef="uref_1489602641">1087845.4081</us-gaap:InvestmentOwnedBalanceContracts>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="cref_865381281"
      decimals="0"
      id="fc_865381281"
      unitRef="uref_1042948581">58533802</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_1694967875"
      decimals="0"
      id="fc_1893996833"
      unitRef="uref_1042948581">71177725</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="cref_1193439043"
      decimals="4"
      id="fc_533837556"
      unitRef="uref_1489602641">1</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedBalanceContracts
      contextRef="cref_408845929"
      decimals="4"
      id="ixv-3274"
      unitRef="uref_1489602641">1087845.4081</us-gaap:InvestmentOwnedBalanceContracts>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="cref_2054357979"
      decimals="0"
      id="ixv-3275"
      unitRef="uref_1042948581">58533802</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_124896620"
      decimals="0"
      id="ixv-3276"
      unitRef="uref_1042948581">71177725</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="cref_24691696"
      decimals="4"
      id="ixv-3277"
      unitRef="uref_1489602641">1</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities
      contextRef="cref_1694967875"
      decimals="0"
      id="ixv-3278"
      unitRef="uref_1042948581">-2736</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets
      contextRef="cref_1193439043"
      decimals="4"
      id="ixv-3279"
      unitRef="uref_1489602641">-0</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets>
    <us-gaap:AssetsNet
      contextRef="cref_1694967875"
      decimals="0"
      id="ixv-3280"
      unitRef="uref_1042948581">71174989</us-gaap:AssetsNet>
    <thyp:PercentageOfNetAssets
      contextRef="cref_1193439043"
      decimals="4"
      id="ixv-3281"
      unitRef="uref_1489602641">1</thyp:PercentageOfNetAssets>
    <thyp:PercentageOfTrustStakedInvestmentHoldings
      contextRef="cref_179931627"
      decimals="4"
      id="ixv-3283"
      unitRef="uref_1489602641">0.8592</thyp:PercentageOfTrustStakedInvestmentHoldings>
    <thyp:PercentageOfTrustStakedInvestmentHoldings
      contextRef="cref_1474050272"
      decimals="4"
      id="ixv-3285"
      unitRef="uref_1489602641">0.9443</thyp:PercentageOfTrustStakedInvestmentHoldings>
    <us-gaap:InvestmentIncomeNet
      contextRef="cref_491529723"
      decimals="0"
      id="fc_491529723"
      unitRef="uref_1042948581">333391</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="cref_319941239"
      decimals="0"
      id="fc_2090963384"
      unitRef="uref_1042948581">333391</us-gaap:InvestmentIncomeNet>
    <us-gaap:SponsorFees
      contextRef="cref_319941239"
      decimals="0"
      id="fc_425164440"
      unitRef="uref_1042948581">50179</us-gaap:SponsorFees>
    <thyp:StakingFee
      contextRef="cref_319941239"
      decimals="0"
      id="fc_144611834"
      unitRef="uref_1042948581">65247</thyp:StakingFee>
    <us-gaap:OperatingExpenses
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1220959562"
      unitRef="uref_1042948581">115426</us-gaap:OperatingExpenses>
    <us-gaap:NetInvestmentIncome
      contextRef="cref_319941239"
      decimals="0"
      id="fc_300858975"
      unitRef="uref_1042948581">217965</us-gaap:NetInvestmentIncome>
    <thyp:NetRealizedLossOnInkindLiabilitiesPaid
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1638172232"
      unitRef="uref_1042948581">5995</thyp:NetRealizedLossOnInkindLiabilitiesPaid>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1069639915"
      unitRef="uref_1042948581">113007</us-gaap:RealizedInvestmentGainsLosses>
    <thyp:NetRealizedGainOnInvestmentInHYPESoldForDistributions
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1728963019"
      unitRef="uref_1042948581">2296556</thyp:NetRealizedGainOnInvestmentInHYPESoldForDistributions>
    <thyp:NetRealizedGainOnInvestmentInHYPEDistributedForInKindRedemptions
      contextRef="cref_319941239"
      decimals="0"
      id="fc_36202461"
      unitRef="uref_1042948581">1310590</thyp:NetRealizedGainOnInvestmentInHYPEDistributedForInKindRedemptions>
    <us-gaap:RealizedGainLossSecuritySoldShortOperating
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1715314990"
      unitRef="uref_1042948581">15613</us-gaap:RealizedGainLossSecuritySoldShortOperating>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="cref_319941239"
      decimals="0"
      id="fc_507978301"
      unitRef="uref_1042948581">18140784</us-gaap:UnrealizedGainLossOnInvestments>
    <thyp:NetChangeInUnrealizedGainLossOnSponsorFeePayable
      contextRef="cref_319941239"
      decimals="0"
      id="fc_627146256"
      unitRef="uref_1042948581">-308</thyp:NetChangeInUnrealizedGainLossOnSponsorFeePayable>
    <us-gaap:GainLossOnInvestments
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1898376236"
      unitRef="uref_1042948581">21870247</us-gaap:GainLossOnInvestments>
    <us-gaap:ProfitLoss
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1528281662"
      unitRef="uref_1042948581">22088212</us-gaap:ProfitLoss>
    <us-gaap:StockholdersEquity
      contextRef="cref_1474050272"
      decimals="0"
      id="fc_1214535169"
      unitRef="uref_1042948581">71174989</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1641535774"
      unitRef="uref_1042948581">13334689</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1023294057"
      unitRef="uref_1042948581">15477513</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <thyp:IncomeDistributions
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1758181250"
      unitRef="uref_1042948581">-338707</thyp:IncomeDistributions>
    <us-gaap:NetInvestmentIncome
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1943067888"
      unitRef="uref_1042948581">217965</us-gaap:NetInvestmentIncome>
    <thyp:NetRealizedLossOnInkindLiabilitiesPaid
      contextRef="cref_319941239"
      decimals="0"
      id="fc_488197162"
      unitRef="uref_1042948581">5995</thyp:NetRealizedLossOnInkindLiabilitiesPaid>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="cref_319941239"
      decimals="0"
      id="fc_395078499"
      unitRef="uref_1042948581">113007</us-gaap:RealizedInvestmentGainsLosses>
    <thyp:NetRealizedGainOnInvestmentInHYPESoldForCashRedemptions
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1708398178"
      unitRef="uref_1042948581">2296556</thyp:NetRealizedGainOnInvestmentInHYPESoldForCashRedemptions>
    <thyp:NetRealizedGainOnInvestmentInHYPEDistributedForInKindRedemptions
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1819430525"
      unitRef="uref_1042948581">1310590</thyp:NetRealizedGainOnInvestmentInHYPEDistributedForInKindRedemptions>
    <us-gaap:RealizedGainLossSecuritySoldShortOperating
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1854229798"
      unitRef="uref_1042948581">15613</us-gaap:RealizedGainLossSecuritySoldShortOperating>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="cref_319941239"
      decimals="0"
      id="fc_975365104"
      unitRef="uref_1042948581">18140784</us-gaap:UnrealizedGainLossOnInvestments>
    <thyp:NetChangeInUnrealizedGainLossOnSponsorFeePayable
      contextRef="cref_319941239"
      decimals="0"
      id="fc_2855794"
      unitRef="uref_1042948581">-308</thyp:NetChangeInUnrealizedGainLossOnSponsorFeePayable>
    <us-gaap:StockholdersEquity
      contextRef="cref_179931627"
      decimals="0"
      id="fc_173996789"
      unitRef="uref_1042948581">90781670</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_319941239"
      decimals="0"
      id="fc_993781903"
      unitRef="uref_1942895230">280000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="cref_319941239"
      decimals="0"
      id="fc_877473242"
      unitRef="uref_1942895230">390000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="cref_319941239"
      decimals="0"
      id="fc_886546308"
      unitRef="uref_1942895230">-110000</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cref_319941239" id="ixv-1370">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;" width="100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt; &lt;/td&gt;&lt;td style="width: 0.25in;"&gt;1.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Organization&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="margin-top: 0; margin-bottom: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;21Shares Hyperliquid Staking ETF (the &#x201c;Trust&#x201d;) is a Delaware statutory trust, formed on July 24, 2025, pursuant to the Delaware Statutory Trust Act (&#x201c;DSTA&#x201d;). The Trust was initially registered with the name of Jura Pentium Trust 13. The Trust changed its name from Jura Pentium Trust 13 to 21Shares Hyperliquid ETF on October 27, 2025. The Trust changed its name from 21Shares Hyperliquid ETF to 21Shares Hyperliquid Staking ETF on August 25, 2026. The Trust operates pursuant to a Second Amended and Restated Trust Agreement (the &#x201c;Trust Agreement&#x201d;). CSC Delaware Trust Company, a Delaware trust company, is the trustee of the Trust (the &#x201c;Trustee&#x201d;). The Trust is managed and controlled by 21Shares US LLC (the &#x201c;Sponsor&#x201d;). The Sponsor is a limited liability company formed in the state of Delaware on June 16, 2021, and is a wholly owned subsidiary of 21co Holdings Limited. The ultimate parent company of 21co Holdings Limited is FalconX Holdings Limited (&#x201c;FalconX&#x201d;). Anchorage Digital Bank N.A. (&#x201c;Anchorage&#x201d;) and BitGo Bank &amp;amp; Trust, N.A. (&#x201c;BitGo,&#x201d; and together with Anchorage, the &#x201c;HYPE Custodians&#x201d;, and each a &#x201c;HYPE Custodian&#x201d;) are the custodians for the Trust and hold all of the Trust&#x2019;s HYPE on the Trust&#x2019;s behalf. The transfer agent (the &#x201c;Transfer Agent&#x201d;), the administrator for the Trust (the &#x201c;Administrator&#x201d;), and the cash custodian (the &#x201c;Cash Custodian&#x201d;), is Bank of New York Mellon.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust is an exchange-traded fund (&#x201c;ETF&#x201d;) that issues common shares of beneficial interest (the &#x201c;Shares&#x201d;) that trade on the Nasdaq Stock Market LLC (the &#x201c;Exchange&#x201d;) under the ticker symbol &#x201c;THYP&#x201d;.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust&#x2019;s investment objective is to seek to track the performance of HYPE as measured by the performance of the FTSE Hyperliquid Index (the &#x201c;Pricing Benchmark&#x201d;), adjusted for the Trust&#x2019;s expenses and other liabilities, and to reflect rewards from staking a portion of the Trust&#x2019;s HYPE, to the extent the Sponsor in its sole discretion determines that the Trust may do so without undue legal or regulatory risk, such as, without limitation, the risk of jeopardizing the Trust&#x2019;s ability to qualify as a grantor trust for tax purposes. The Pricing Benchmark is calculated by FTSE International Limited (the &#x201c;Pricing Benchmark Provider&#x201d;) based on the volume weighted average price across qualifying HYPE spot markets. The Pricing Benchmark is designed to reflect the performance of HYPE in U.S. dollars. In seeking to achieve its investment objective, the Trust holds HYPE and values its Shares daily as of 4:00 p.m. ET based on the Pricing Benchmark.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust is an &#x201c;emerging growth company&#x201d; as that term is used in the Securities Act and, as such, the Trust may elect to comply with certain reduced public company reporting requirements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; On March 18, 2026, the Sponsor, in its capacity as seed capital investor (the &#x201c;Seed Capital Investor&#x201d;), subject to conditions, purchased &lt;span style="-sec-ix-hidden:fc_104605228;"&gt;two&lt;/span&gt; Shares at a per-Share price of $50.00 (the &#x201c;Initial Seed Shares&#x201d;). Total proceeds to the Trust from the sale of these Initial Seed Shares were $100. Delivery of the Initial Seed Shares was made on March 18, 2026. These Initial Seed Shares were redeemed for cash on March 23, 2026. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; On May 11, 2026, the Sponsor, in its capacity as the Seed Capital Investor, subject to conditions, purchased 20,000 Shares (the &#x201c;Seed Creation Baskets&#x201d;) at a per-Share price of $24.40. In its capacity as the Seed Capital Investor, the Sponsor has acted as a statutory underwriter in connection with such purchase. Total proceeds to the Trust from the sale of the Seed Creation Baskets were $488,079. Delivery of the Seed Creation Baskets was made on May 11, 2026. On May 11, 2026, the Trust purchased HYPE with the proceeds of the Seed Creation Baskets by transacting with a designated third party, who may be an Authorized Participant or an affiliate of an Authorized Participant, and with whom the Sponsor has entered into an agreement on behalf of the Trust (each such third party, a &#x201c;HYPE Counterparty&#x201d;) to acquire HYPE on behalf of the Trust in exchange for cash provided by the Sponsor in its capacity as Seed Capital Investor. All HYPE acquired in connection with the Seed Creation Baskets is held by one or more of the HYPE Custodians. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The statement of assets and liabilities and schedule of investment on September 30, 2026, and the statement of operations and changes in net assets for the three months ended September 30, 2026 have been prepared on behalf of the Trust and are unaudited. In the opinion of management of the Sponsor of the Trust, all adjustments (which include normal recurring adjustments) necessary to present fairly the financial position and results of operations for the three months ended September 30, 2026, have been included. In addition, interim period results are not necessarily indicative of results for a full-year period.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The fiscal year-end of the Trust is June 30&lt;sup&gt;th&lt;/sup&gt;.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <thyp:InceptionDate contextRef="cref_319941239" id="ixv-3319">March 18, 2026</thyp:InceptionDate>
    <us-gaap:InvestmentCompanyIssuanceOfSharesPerShare
      contextRef="cref_1432048928"
      decimals="2"
      id="ixv-3320"
      unitRef="uref_179931627">50</us-gaap:InvestmentCompanyIssuanceOfSharesPerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="cref_1432048928"
      decimals="0"
      id="ixv-3321"
      unitRef="uref_1042948581">100</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_171125964"
      decimals="0"
      id="ixv-3322"
      unitRef="uref_1942895230">20000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:InvestmentCompanyIssuanceOfSharesPerShare
      contextRef="cref_171125964"
      decimals="2"
      id="ixv-3323"
      unitRef="uref_179931627">24.4</us-gaap:InvestmentCompanyIssuanceOfSharesPerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="cref_171125964"
      decimals="0"
      id="ixv-3324"
      unitRef="uref_1042948581">488079</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_319941239" id="ixv-1404">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;" width="100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt; &lt;/td&gt;&lt;td style="width: 0.25in;"&gt;2.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="margin-top: 0; margin-bottom: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Basis of Accounting&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d; or &#x201c;GAAP&#x201d;).&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust qualifies as an investment company solely for accounting purposes and not for any other purpose and follows the accounting and reporting guidance under the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 946, Financial Services - Investment Companies, but is not registered, and is not required to be registered, as an investment company under the Investment Company Act of 1940, as amended (the &#x201c;1940 Act&#x201d;). The Trust uses fair value as its method of accounting for HYPE in accordance with its classification as an investment company for accounting purposes.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;As an investment company for accounting purposes, the Trust is exempt from the requirement to present a statement of cash flows pursuant to ASC Topic 230, Statement of Cash Flows. Accordingly, a statement of cash flows has not been presented.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Accounting Estimates&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The preparation of the financial statements in conformity with US GAAP requires the Trust to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from such estimates as additional information becomes available or actual amounts may become determinable. Should actual results differ from those previously recognized, the recorded estimates will be revised accordingly with the impact reflected in the operating results of the Trust in the reporting period in which they become known.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Cash&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Cash includes non-interest bearing, non-restricted cash maintained with one financial institution that at times may exceed U.S. federally insured limits.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Investment Valuation&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;US GAAP defines fair value as the price the Trust would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. The Trust&#x2019;s policy is to value investments held at fair value.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust identifies and determines the HYPE principal market (or in the absence of a principal market, the most advantageous market) for GAAP purposes consistent with the application of the fair value measurement framework in FASB ASC 820 &#x2013; Fair Value Measurement. A principal market is the market with the greatest volume and activity level for the asset or liability. The determination of the principal market will be based on the market with the greatest volume and level of activity that can be accessed. The Trust obtains relevant volume and level of activity information and based on initial analysis will select an exchange market as the Trust&#x2019;s principal market. The net asset value (&#x201c;NAV&#x201d;) and NAV per Share will be calculated using the fair value of HYPE based on the price provided by this exchange market, as of 4:00 p.m. ET on the measurement date for GAAP purposes. The Trust will update its principal market analysis periodically and as needed to the extent that events have occurred, or activities have changed in a manner that could change the Sponsor&#x2019;s determination of the Trust&#x2019;s principal market.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Various inputs are used in determining the fair value of assets and liabilities. Inputs may be based on independent market data (&#x201c;observable inputs&#x201d;), or they may be internally developed (&#x201c;unobservable inputs&#x201d;). These inputs are categorized into a disclosure hierarchy consisting of three broad levels for financial reporting purposes. The level of a value determined for an asset or liability within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are as follows:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly or indirectly, including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not considered to be active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means; and&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;Level 3: Unobservable inputs, including the Trust&#x2019;s assumptions used in determining the fair value of investments, where there is little or no market activity for the asset or liability at the measurement date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The following tables present information about the Trust&#x2019;s assets measured at fair value as of September 30, 2026 (Unaudited) and June 30, 2026:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center;"&gt;Amount at&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value Measurement Using&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 1&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 2&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 3&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold;"&gt;September 30, 2026 (Unaudited)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding-left: 0.125in; font-weight: bold;"&gt;Assets&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; padding-left: 0.25in;"&gt;Investment in HYPE&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;90,783,674&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;90,783,674&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1004901826;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_491627755;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center;"&gt;Amount at&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value Measurement Using&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 1&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 2&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 3&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold;"&gt;June 30, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding-left: 0.125in; font-weight: bold;"&gt;Assets&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; padding-left: 0.25in;"&gt;Investment in HYPE&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;71,177,725&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;71,177,725&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1876435551;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_861537726;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The cost basis of the investment in HYPE recorded by the Trust for financial reporting purposes is the fair value of HYPE at the time of purchase. The cost basis recorded by the Trust may differ from proceeds collected by the Authorized Participant (as defined below) from the sale of the corresponding Shares to investors.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Investment Transactions&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust considers investment transactions to be the receipt of HYPE for Share creations and the delivery of HYPE for Share redemptions or for payment of expenses in HYPE. The Trust records its investment transactions on a trade date basis and changes in fair value are reflected as net change in unrealized appreciation or depreciation on investments and the net change in unrealized appreciation or depreciation on Sponsor Fee payable. Realized gains and losses are calculated using the specific identification method. Realized gains and losses are recognized in connection with transactions including redemption of Shares, settling obligations for the Sponsor Fee and the in-kind liabilities paid in connection to the Sponsor Fee in HYPE.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; The Trust earns staking rewards by delegating a portion of its HYPE on the Hyperliquid Network&#x2019;s proof-of-stake consensus protocol. The Sponsor has entered into a staking agreement (as amended, the &#x201c;Staking Services Agreement&#x201d;) with Figment Inc., a Canadian corporation (the &#x201c;Staking Services Provider&#x201d;), to facilitate the staking of the Trust&#x2019;s HYPE. Each Staking Services Provider that generates staking rewards is entitled to compensation determined as a portion of the staking rewards (the &#x201c;Staking Provider Consideration&#x201d;). The Sponsor, the Staking Services Provider and HYPE Custodians receive an aggregate of 30% of the staking rewards, with the remainder to be distributed to Shareholders at least quarterly in the form of cash distributions. Staking rewards represent variable consideration based on a variety of factors such as the amount of the HYPE holdings the Trust has made available to the network, the staking yield, and other factors, for its contribution to the network. The Trust retains control of its HYPE throughout the staking process. The delegation of HYPE for staking purposes does not constitute a sale, transfer, or other derecognition event, as control of the HYPE is not transferred to the validator or Staking Services Provider. Staking rewards are recorded as staking income recognized at fair value when earned. Because the Trust is not the principal to the block validation service, it does not control the full output of the reward-generating activity, and instead earns net staking rewards, after the Staking Provider Consideration is deducted (&#x201c;Staking Rewards&#x201d;). The rewards owed or paid to the Staking Services Provider reduce the amount of HYPE rewards that are generated from the Trust&#x2019;s staking activities (&#x201c;Staking Activities&#x201d;) that are available in the assets of the Trust. As such, the Trust presents staking rewards on a net basis, reflecting transaction cost and only the portion of protocol rewards to which it is entitled. Staking Rewards are received in general daily at the HYPE Custodians&#x2019; accounts, as earned. The unbonding period for staked HYPE is a fixed seven-day period mandated by the network protocol following the Sponsor&#x2019;s request to unstake such assets in addition to the one-day lockup period to unstake HYPE from a specific validator, with the Trust&#x2019;s HYPE becoming available for transfer upon completion of the applicable unbonding period. The Trust&#x2019;s staked HYPE is unable to be moved on the blockchain or traded during this period. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust recognizes Staking Rewards as revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). Under the staking arrangements, the validator (e.g., the HYPE Custodian or other Staking Services Provider) is considered the customer, as it receives access to the Trust&#x2019;s staking capacity (i.e., the delegation of HYPE), which represents the Trust&#x2019;s performance obligation. In exchange, the Trust is entitled to staking rewards generated by the Hyperliquid Network, net of validator fees. Staking rewards represent variable consideration, as the amount of rewards is not known until the applicable validation activities are completed, and the Trust receives rewards in its custodial account. The contract term is the length of each staking epoch. Staking rewards are recognized as revenue when the Trust satisfies its performance obligations. Staking rewards are received in HYPE, which represents non-cash consideration. Non-cash consideration is measured at fair value at the date of inception of each contract in accordance with ASC 606.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; Temporary lock-up periods or transfer restrictions from staking could limit the Trust&#x2019;s ability to meet redemptions. For the three months ended September 30, 2026, the Trust staked an average of 91.04% of its HYPE holdings on a daily basis. As of September 30, 2026 and June 30, 2026, the Trust had staked 85.92% and 94.43%, respectively, of its HYPE holdings. The staked percentage as of any particular date, including at the end of a reporting period, may differ from the quarterly average. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor Fee payable is settled in HYPE. The liability is remeasured at each reporting date by reference to the fair value of the HYPE required to settle it, with the effect of remeasurement recognized in net change in unrealized appreciation (depreciation) on the Sponsor Fee payable. On settlement, the difference between the carrying amount of the liability and the fair value of the HYPE delivered is recognized as a net realized gain (loss) on in-kind liabilities paid.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Distributions to Shareholders&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust pays cash distributions to Shareholders at least quarterly. Distributions are funded from staking rewards earned on the Trust&#x2019;s HYPE holdings. Staking Rewards are recognized as income by the Trust on a daily basis as they accrue and are reflected in the Trust&#x2019;s NAV prior to distribution.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Distributions to Shareholders are recorded on the ex-dividend date, which also serves as the record date. Shareholders of record as of the ex-dividend date are entitled to receive distributions paid on the applicable payment date. The amount of each distribution is based on the staking rewards actually earned by the Trust during the relevant period, net of the Staking Provider Consideration and the Staking Fee (as defined below). Distributions are reflected as a reduction of net assets as of the ex-dividend date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The tax character of distributions is determined annually in accordance with U.S. federal income tax principles, which may differ from the treatment of such amounts for GAAP purposes. Any differences between the tax and book distributable amounts are reclassified within the components of net assets at year-end.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; During the three months ended September 30, 2026, the Trust declared a distribution to Shareholders derived from a portion of the HYPE received as Staking Rewards from the Trust&#x2019;s staking activities, of $338,707, or $0.191360 per Share, on September 29, 2026. The distributions reduced the Trust&#x2019;s HYPE holdings through the sale of HYPE to generate cash. As of September 30, 2026, the distribution declared on September 29, 2026 had not yet been paid and is reflected as Distribution payable of $338,707 on the Statements of Assets and Liabilities. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Calculation of NAV and NAV per Share&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;On each day other than when the Exchange is closed for regular trading (a &#x201c;Business Day&#x201d;), as soon as practicable after 4:00 p.m. ET, the NAV of the Trust is obtained by subtracting all accrued fees, expenses and other liabilities of the Trust from the value of the HYPE and other assets held by the Trust based on the Pricing Benchmark price. The Administrator computes the NAV per Share by dividing the NAV of the Trust by the number of Shares outstanding on the date the computation is made.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Federal Income Taxes&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor and the Trustee will treat the Trust as a &#x201c;grantor trust&#x201d; for U.S. federal income tax purposes. As a grantor trust, the Trust can undertake only certain types of activities. For example, generally, the Trust cannot vary its investment portfolio to take advantage of market fluctuations. The Trust may receive income from investment activities that do not require such decision-making. If staking is treated for U.S. federal income tax purposes as a passive ministerial and administrative activity, it should be permissible for the Trust. To that end, on November 10, 2025, the Treasury Department and IRS issued a revenue procedure that provided a safe harbor for trusts that otherwise qualify as investment trusts and as grantor trusts to stake their digital assets without jeopardizing their tax status as investment trusts and grantor trusts for U.S. federal income tax purposes. The revenue procedure provides specific requirements that must be satisfied by a Trust in order to be eligible to rely on the safe harbor. The Trust intends to operate so that it will qualify to be treated for U.S. federal income tax purposes as a grantor trust.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Because the treatment of staking in a grantor trust, including interpretation of the requirements under the safe harbor, is still developing, there remains a risk of adverse regulatory or legal determinations that could affect the tax treatment of the Trust as a grantor trust or affect the Trust&#x2019;s operations.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Each beneficial owner of Shares will be treated as directly owning its pro rata share of the Trust&#x2019;s assets and a pro rata portion of the Trust&#x2019;s income, gain, losses and deductions. If the Trust sells HYPE (for example, to pay fees or expenses), such a sale is a taxable event to shareholders of the Trust (&#x201c;Shareholders&#x201d;). Upon a Shareholder&#x2019;s sale of its Shares, the Shareholder will be treated as having sold the pro rata share of the HYPE held in the Trust at the time of the sale and recognizes a gain or loss on such sale.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor has reviewed the tax positions as of September 30, 2026 and June 30, 2026, and has determined that no provision for income tax is required in the Trust&#x2019;s financial statements.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Segment Reporting&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; The Trust operates in one segment. The segment derives its revenues from Trust investments made in accordance with the defined investment strategy of the Trust, as prescribed in the Trust&#x2019;s prospectus. The Chief Operating Decision Maker (&#x201c;CODM&#x201d;) is the &lt;span style="-sec-ix-hidden:fc_186673792;"&gt;Chief Executive Officer&lt;/span&gt; of the Sponsor. The CODM monitors the operating results of the Trust. The financial information that the CODM leverages to assess the segment&#x2019;s performance and to make decisions for the Trust&#x2019;s single segment is consistent with the financial information that is presented within the Trust&#x2019;s financial statements. Segment assets are reflected on the accompanying Statement of Assets and Liabilities as Total assets and the only significant segment expenses, the Sponsor Fee and the Staking Fee, are included in the accompanying Statement of Operations. &lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="cref_319941239" id="ixv-1413">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Basis of Accounting&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;US GAAP&#x201d; or &#x201c;GAAP&#x201d;).&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust qualifies as an investment company solely for accounting purposes and not for any other purpose and follows the accounting and reporting guidance under the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 946, Financial Services - Investment Companies, but is not registered, and is not required to be registered, as an investment company under the Investment Company Act of 1940, as amended (the &#x201c;1940 Act&#x201d;). The Trust uses fair value as its method of accounting for HYPE in accordance with its classification as an investment company for accounting purposes.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;As an investment company for accounting purposes, the Trust is exempt from the requirement to present a statement of cash flows pursuant to ASC Topic 230, Statement of Cash Flows. Accordingly, a statement of cash flows has not been presented.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <thyp:AccountingEstimatesPolicyTextBlock contextRef="cref_319941239" id="ixv-1423">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Accounting Estimates&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The preparation of the financial statements in conformity with US GAAP requires the Trust to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from such estimates as additional information becomes available or actual amounts may become determinable. Should actual results differ from those previously recognized, the recorded estimates will be revised accordingly with the impact reflected in the operating results of the Trust in the reporting period in which they become known.&lt;/p&gt;</thyp:AccountingEstimatesPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="cref_319941239" id="ixv-1429">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Cash&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Cash includes non-interest bearing, non-restricted cash maintained with one financial institution that at times may exceed U.S. federally insured limits.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueTransferPolicyPolicyTextBlock contextRef="cref_319941239" id="ixv-1442">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Investment Valuation&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;US GAAP defines fair value as the price the Trust would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. The Trust&#x2019;s policy is to value investments held at fair value.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust identifies and determines the HYPE principal market (or in the absence of a principal market, the most advantageous market) for GAAP purposes consistent with the application of the fair value measurement framework in FASB ASC 820 &#x2013; Fair Value Measurement. A principal market is the market with the greatest volume and activity level for the asset or liability. The determination of the principal market will be based on the market with the greatest volume and level of activity that can be accessed. The Trust obtains relevant volume and level of activity information and based on initial analysis will select an exchange market as the Trust&#x2019;s principal market. The net asset value (&#x201c;NAV&#x201d;) and NAV per Share will be calculated using the fair value of HYPE based on the price provided by this exchange market, as of 4:00 p.m. ET on the measurement date for GAAP purposes. The Trust will update its principal market analysis periodically and as needed to the extent that events have occurred, or activities have changed in a manner that could change the Sponsor&#x2019;s determination of the Trust&#x2019;s principal market.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Various inputs are used in determining the fair value of assets and liabilities. Inputs may be based on independent market data (&#x201c;observable inputs&#x201d;), or they may be internally developed (&#x201c;unobservable inputs&#x201d;). These inputs are categorized into a disclosure hierarchy consisting of three broad levels for financial reporting purposes. The level of a value determined for an asset or liability within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are as follows:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly or indirectly, including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not considered to be active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means; and&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;Level 3: Unobservable inputs, including the Trust&#x2019;s assumptions used in determining the fair value of investments, where there is little or no market activity for the asset or liability at the measurement date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The following tables present information about the Trust&#x2019;s assets measured at fair value as of September 30, 2026 (Unaudited) and June 30, 2026:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center;"&gt;Amount at&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value Measurement Using&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 1&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 2&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 3&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold;"&gt;September 30, 2026 (Unaudited)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding-left: 0.125in; font-weight: bold;"&gt;Assets&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; padding-left: 0.25in;"&gt;Investment in HYPE&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;90,783,674&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;90,783,674&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1004901826;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_491627755;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center;"&gt;Amount at&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value Measurement Using&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 1&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 2&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 3&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold;"&gt;June 30, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding-left: 0.125in; font-weight: bold;"&gt;Assets&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; padding-left: 0.25in;"&gt;Investment in HYPE&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;71,177,725&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;71,177,725&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1876435551;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_861537726;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;/p&gt;      &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The cost basis of the investment in HYPE recorded by the Trust for financial reporting purposes is the fair value of HYPE at the time of purchase. The cost basis recorded by the Trust may differ from proceeds collected by the Authorized Participant (as defined below) from the sale of the corresponding Shares to investors.&lt;/p&gt;</us-gaap:FairValueTransferPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="cref_319941239" id="ixv-1458">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The following tables present information about the Trust&#x2019;s assets measured at fair value as of September 30, 2026 (Unaudited) and June 30, 2026:&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center;"&gt;Amount at&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value Measurement Using&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 1&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 2&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 3&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold;"&gt;September 30, 2026 (Unaudited)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding-left: 0.125in; font-weight: bold;"&gt;Assets&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; padding-left: 0.25in;"&gt;Investment in HYPE&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;90,783,674&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;90,783,674&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1004901826;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_491627755;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center;"&gt;Amount at&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value Measurement Using&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 1&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 2&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Level 3&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold;"&gt;June 30, 2026&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="padding-left: 0.125in; font-weight: bold;"&gt;Assets&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 52%; text-align: left; padding-left: 0.25in;"&gt;Investment in HYPE&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;71,177,725&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;71,177,725&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1876435551;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_861537726;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_179931627"
      decimals="0"
      id="ixv-3325"
      unitRef="uref_1042948581">90783674</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_914890394"
      decimals="0"
      id="ixv-3326"
      unitRef="uref_1042948581">90783674</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_1474050272"
      decimals="0"
      id="ixv-3327"
      unitRef="uref_1042948581">71177725</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_2105076071"
      decimals="0"
      id="ixv-3328"
      unitRef="uref_1042948581">71177725</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentPolicyTextBlock contextRef="cref_319941239" id="ixv-1616">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Investment Transactions&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust considers investment transactions to be the receipt of HYPE for Share creations and the delivery of HYPE for Share redemptions or for payment of expenses in HYPE. The Trust records its investment transactions on a trade date basis and changes in fair value are reflected as net change in unrealized appreciation or depreciation on investments and the net change in unrealized appreciation or depreciation on Sponsor Fee payable. Realized gains and losses are calculated using the specific identification method. Realized gains and losses are recognized in connection with transactions including redemption of Shares, settling obligations for the Sponsor Fee and the in-kind liabilities paid in connection to the Sponsor Fee in HYPE.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; The Trust earns staking rewards by delegating a portion of its HYPE on the Hyperliquid Network&#x2019;s proof-of-stake consensus protocol. The Sponsor has entered into a staking agreement (as amended, the &#x201c;Staking Services Agreement&#x201d;) with Figment Inc., a Canadian corporation (the &#x201c;Staking Services Provider&#x201d;), to facilitate the staking of the Trust&#x2019;s HYPE. Each Staking Services Provider that generates staking rewards is entitled to compensation determined as a portion of the staking rewards (the &#x201c;Staking Provider Consideration&#x201d;). The Sponsor, the Staking Services Provider and HYPE Custodians receive an aggregate of 30% of the staking rewards, with the remainder to be distributed to Shareholders at least quarterly in the form of cash distributions. Staking rewards represent variable consideration based on a variety of factors such as the amount of the HYPE holdings the Trust has made available to the network, the staking yield, and other factors, for its contribution to the network. The Trust retains control of its HYPE throughout the staking process. The delegation of HYPE for staking purposes does not constitute a sale, transfer, or other derecognition event, as control of the HYPE is not transferred to the validator or Staking Services Provider. Staking rewards are recorded as staking income recognized at fair value when earned. Because the Trust is not the principal to the block validation service, it does not control the full output of the reward-generating activity, and instead earns net staking rewards, after the Staking Provider Consideration is deducted (&#x201c;Staking Rewards&#x201d;). The rewards owed or paid to the Staking Services Provider reduce the amount of HYPE rewards that are generated from the Trust&#x2019;s staking activities (&#x201c;Staking Activities&#x201d;) that are available in the assets of the Trust. As such, the Trust presents staking rewards on a net basis, reflecting transaction cost and only the portion of protocol rewards to which it is entitled. Staking Rewards are received in general daily at the HYPE Custodians&#x2019; accounts, as earned. The unbonding period for staked HYPE is a fixed seven-day period mandated by the network protocol following the Sponsor&#x2019;s request to unstake such assets in addition to the one-day lockup period to unstake HYPE from a specific validator, with the Trust&#x2019;s HYPE becoming available for transfer upon completion of the applicable unbonding period. The Trust&#x2019;s staked HYPE is unable to be moved on the blockchain or traded during this period. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust recognizes Staking Rewards as revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (&#x201c;ASC 606&#x201d;). Under the staking arrangements, the validator (e.g., the HYPE Custodian or other Staking Services Provider) is considered the customer, as it receives access to the Trust&#x2019;s staking capacity (i.e., the delegation of HYPE), which represents the Trust&#x2019;s performance obligation. In exchange, the Trust is entitled to staking rewards generated by the Hyperliquid Network, net of validator fees. Staking rewards represent variable consideration, as the amount of rewards is not known until the applicable validation activities are completed, and the Trust receives rewards in its custodial account. The contract term is the length of each staking epoch. Staking rewards are recognized as revenue when the Trust satisfies its performance obligations. Staking rewards are received in HYPE, which represents non-cash consideration. Non-cash consideration is measured at fair value at the date of inception of each contract in accordance with ASC 606.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; Temporary lock-up periods or transfer restrictions from staking could limit the Trust&#x2019;s ability to meet redemptions. For the three months ended September 30, 2026, the Trust staked an average of 91.04% of its HYPE holdings on a daily basis. As of September 30, 2026 and June 30, 2026, the Trust had staked 85.92% and 94.43%, respectively, of its HYPE holdings. The staked percentage as of any particular date, including at the end of a reporting period, may differ from the quarterly average. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor Fee payable is settled in HYPE. The liability is remeasured at each reporting date by reference to the fair value of the HYPE required to settle it, with the effect of remeasurement recognized in net change in unrealized appreciation (depreciation) on the Sponsor Fee payable. On settlement, the difference between the carrying amount of the liability and the fair value of the HYPE delivered is recognized as a net realized gain (loss) on in-kind liabilities paid.&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <thyp:StakingRewardsPercentage
      contextRef="cref_319941239"
      decimals="2"
      id="ixv-3329"
      unitRef="uref_1489602641">0.30</thyp:StakingRewardsPercentage>
    <thyp:PercentageOfTrustStakedInvestmentHoldingsOnDailyBasis
      contextRef="cref_319941239"
      decimals="4"
      id="ixv-3330"
      unitRef="uref_1489602641">0.9104</thyp:PercentageOfTrustStakedInvestmentHoldingsOnDailyBasis>
    <thyp:PercentageOfTrustStakedInvestmentHoldings
      contextRef="cref_179931627"
      decimals="4"
      id="ixv-3331"
      unitRef="uref_1489602641">0.8592</thyp:PercentageOfTrustStakedInvestmentHoldings>
    <thyp:PercentageOfTrustStakedInvestmentHoldings
      contextRef="cref_1474050272"
      decimals="4"
      id="ixv-3332"
      unitRef="uref_1489602641">0.9443</thyp:PercentageOfTrustStakedInvestmentHoldings>
    <thyp:DistributionsToShareholdersPolicyTextBlock contextRef="cref_319941239" id="ixv-1630">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Distributions to Shareholders&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust pays cash distributions to Shareholders at least quarterly. Distributions are funded from staking rewards earned on the Trust&#x2019;s HYPE holdings. Staking Rewards are recognized as income by the Trust on a daily basis as they accrue and are reflected in the Trust&#x2019;s NAV prior to distribution.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Distributions to Shareholders are recorded on the ex-dividend date, which also serves as the record date. Shareholders of record as of the ex-dividend date are entitled to receive distributions paid on the applicable payment date. The amount of each distribution is based on the staking rewards actually earned by the Trust during the relevant period, net of the Staking Provider Consideration and the Staking Fee (as defined below). Distributions are reflected as a reduction of net assets as of the ex-dividend date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The tax character of distributions is determined annually in accordance with U.S. federal income tax principles, which may differ from the treatment of such amounts for GAAP purposes. Any differences between the tax and book distributable amounts are reclassified within the components of net assets at year-end.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; During the three months ended September 30, 2026, the Trust declared a distribution to Shareholders derived from a portion of the HYPE received as Staking Rewards from the Trust&#x2019;s staking activities, of $338,707, or $0.191360 per Share, on September 29, 2026. The distributions reduced the Trust&#x2019;s HYPE holdings through the sale of HYPE to generate cash. As of September 30, 2026, the distribution declared on September 29, 2026 had not yet been paid and is reflected as Distribution payable of $338,707 on the Statements of Assets and Liabilities. &lt;/p&gt;</thyp:DistributionsToShareholdersPolicyTextBlock>
    <us-gaap:CashAvailableForDistributions
      contextRef="cref_119824875"
      decimals="0"
      id="ixv-3333"
      unitRef="uref_1042948581">338707</us-gaap:CashAvailableForDistributions>
    <us-gaap:InvestmentCompanyDistributionToShareholdersPerShare
      contextRef="cref_596655373"
      decimals="6"
      id="ixv-3334"
      unitRef="uref_179931627">0.19136</us-gaap:InvestmentCompanyDistributionToShareholdersPerShare>
    <us-gaap:CashAvailableForDistributions
      contextRef="cref_119824875"
      decimals="0"
      id="ixv-3335"
      unitRef="uref_1042948581">338707</us-gaap:CashAvailableForDistributions>
    <thyp:CalculationOfNAVAndNAVPerSharePolicyTextBlock contextRef="cref_319941239" id="ixv-1649">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Calculation of NAV and NAV per Share&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;On each day other than when the Exchange is closed for regular trading (a &#x201c;Business Day&#x201d;), as soon as practicable after 4:00 p.m. ET, the NAV of the Trust is obtained by subtracting all accrued fees, expenses and other liabilities of the Trust from the value of the HYPE and other assets held by the Trust based on the Pricing Benchmark price. The Administrator computes the NAV per Share by dividing the NAV of the Trust by the number of Shares outstanding on the date the computation is made.&lt;/p&gt;</thyp:CalculationOfNAVAndNAVPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="cref_319941239" id="ixv-1655">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Federal Income Taxes&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor and the Trustee will treat the Trust as a &#x201c;grantor trust&#x201d; for U.S. federal income tax purposes. As a grantor trust, the Trust can undertake only certain types of activities. For example, generally, the Trust cannot vary its investment portfolio to take advantage of market fluctuations. The Trust may receive income from investment activities that do not require such decision-making. If staking is treated for U.S. federal income tax purposes as a passive ministerial and administrative activity, it should be permissible for the Trust. To that end, on November 10, 2025, the Treasury Department and IRS issued a revenue procedure that provided a safe harbor for trusts that otherwise qualify as investment trusts and as grantor trusts to stake their digital assets without jeopardizing their tax status as investment trusts and grantor trusts for U.S. federal income tax purposes. The revenue procedure provides specific requirements that must be satisfied by a Trust in order to be eligible to rely on the safe harbor. The Trust intends to operate so that it will qualify to be treated for U.S. federal income tax purposes as a grantor trust.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Because the treatment of staking in a grantor trust, including interpretation of the requirements under the safe harbor, is still developing, there remains a risk of adverse regulatory or legal determinations that could affect the tax treatment of the Trust as a grantor trust or affect the Trust&#x2019;s operations.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Each beneficial owner of Shares will be treated as directly owning its pro rata share of the Trust&#x2019;s assets and a pro rata portion of the Trust&#x2019;s income, gain, losses and deductions. If the Trust sells HYPE (for example, to pay fees or expenses), such a sale is a taxable event to shareholders of the Trust (&#x201c;Shareholders&#x201d;). Upon a Shareholder&#x2019;s sale of its Shares, the Shareholder will be treated as having sold the pro rata share of the HYPE held in the Trust at the time of the sale and recognizes a gain or loss on such sale.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor has reviewed the tax positions as of September 30, 2026 and June 30, 2026, and has determined that no provision for income tax is required in the Trust&#x2019;s financial statements.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="cref_319941239" id="ixv-1667">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Segment Reporting&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; The Trust operates in one segment. The segment derives its revenues from Trust investments made in accordance with the defined investment strategy of the Trust, as prescribed in the Trust&#x2019;s prospectus. The Chief Operating Decision Maker (&#x201c;CODM&#x201d;) is the &lt;span style="-sec-ix-hidden:fc_186673792;"&gt;Chief Executive Officer&lt;/span&gt; of the Sponsor. The CODM monitors the operating results of the Trust. The financial information that the CODM leverages to assess the segment&#x2019;s performance and to make decisions for the Trust&#x2019;s single segment is consistent with the financial information that is presented within the Trust&#x2019;s financial statements. Segment assets are reflected on the accompanying Statement of Assets and Liabilities as Total assets and the only significant segment expenses, the Sponsor Fee and the Staking Fee, are included in the accompanying Statement of Operations. &lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3336"
      unitRef="uref_1662653229">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_319941239" id="ixv-1672">The Chief Operating Decision Maker (&#x201c;CODM&#x201d;) is the Chief Executive Officer of the Sponsor. The CODM monitors the operating results of the Trust. The financial information that the CODM leverages to assess the segment&#x2019;s performance and to make decisions for the Trust&#x2019;s single segment is consistent with the financial information that is presented within the Trust&#x2019;s financial statements.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="cref_319941239" id="ixv-1681"> &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 24px;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 24px;"&gt;&lt;span style="font-size: 10pt;"&gt;3.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="text-decoration:underline"&gt;Fair Value of HYPE&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The following represents the changes in quantity of HYPE and the fair value during the three months ended on September 30, 2026 (Unaudited):&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Quantity of&lt;br/&gt; HYPE&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%;"&gt;Beginning balance as of July 1, 2026&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,087,845.4081&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;71,177,725&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;HYPE purchased for cash contributions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;81,158.5107&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;6,660,771&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;HYPE received as in-kind contributions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;81,167.3800&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;6,673,918&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;HYPE rewards received (net of Staking Provider Consideration)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;4,938.2047&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;333,391&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;HYPE sold for cash redemptions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(196,947.0255&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(13,031,236&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;HYPE distributed for in-kind redemptions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(28,996.1452&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,446,277&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;HYPE sold to pay expenses&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(1,824.5998&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(122,461&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;HYPE sold for income distribution&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(3,850.4800&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(338,707&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Net realized gain on investment in HYPE sold to pay Sponsor Fee&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_937087038;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;15,613&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Net realized gain on investment in HYPE sold for cash redemptions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1840905536;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,296,556&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Net realized gain on investment in HYPE distributed for in-kind redemptions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1779338889;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,310,590&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Net realized gain on investment in HYPE sold for income distribution&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1546356471;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;113,007&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Net change in unrealized appreciation on investment in HYPE&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_431398733;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;18,140,784&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Ending balance as of September 30, 2026*&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,023,491.2530&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;90,783,674&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;*&lt;/td&gt; &lt;td style="text-align: justify;"&gt;No comparative financial statements have been provided as the Trust did not have any operations as of September 30, 2025.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock contextRef="cref_319941239" id="ixv-1692">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The following represents the changes in quantity of HYPE and the fair value during the three months ended on September 30, 2026 (Unaudited):&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Quantity of&lt;br/&gt; HYPE&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Fair Value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%;"&gt;Beginning balance as of July 1, 2026&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;1,087,845.4081&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;71,177,725&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;HYPE purchased for cash contributions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;81,158.5107&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;6,660,771&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;HYPE received as in-kind contributions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;81,167.3800&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;6,673,918&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;HYPE rewards received (net of Staking Provider Consideration)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;4,938.2047&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;333,391&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;HYPE sold for cash redemptions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(196,947.0255&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(13,031,236&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;HYPE distributed for in-kind redemptions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(28,996.1452&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(2,446,277&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;HYPE sold to pay expenses&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(1,824.5998&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(122,461&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;HYPE sold for income distribution&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(3,850.4800&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;(338,707&lt;/td&gt; &lt;td style="text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Net realized gain on investment in HYPE sold to pay Sponsor Fee&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_937087038;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;15,613&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Net realized gain on investment in HYPE sold for cash redemptions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1840905536;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;2,296,556&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Net realized gain on investment in HYPE distributed for in-kind redemptions&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1779338889;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1,310,590&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Net realized gain on investment in HYPE sold for income distribution&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1546356471;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;113,007&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Net change in unrealized appreciation on investment in HYPE&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_431398733;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;18,140,784&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Ending balance as of September 30, 2026*&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;1,023,491.2530&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;90,783,674&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;*&lt;/td&gt; &lt;td style="text-align: justify;"&gt;No comparative financial statements have been provided as the Trust did not have any operations as of September 30, 2025.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;</us-gaap:InvestmentHoldingsScheduleOfInvestmentsTableTextBlock>
    <us-gaap:InvestmentOwnedBalanceContracts
      contextRef="cref_1474050272"
      decimals="4"
      id="ixv-3337"
      unitRef="uref_1489602641">1087845.4081</us-gaap:InvestmentOwnedBalanceContracts>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_1474050272"
      decimals="0"
      id="ixv-3338"
      unitRef="uref_1042948581">71177725</us-gaap:InvestmentOwnedAtFairValue>
    <thyp:QuantityOfHYPEHYPEPurchasedForCashContributions
      contextRef="cref_319941239"
      decimals="4"
      id="ixv-3339"
      unitRef="uref_1489602641">81158.5107</thyp:QuantityOfHYPEHYPEPurchasedForCashContributions>
    <thyp:FairValueHYPEPurchasedForCashContributions
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3340"
      unitRef="uref_1042948581">6660771</thyp:FairValueHYPEPurchasedForCashContributions>
    <thyp:QuantityOfHYPE
      contextRef="cref_319941239"
      decimals="4"
      id="ixv-3341"
      unitRef="uref_1489602641">81167.38</thyp:QuantityOfHYPE>
    <thyp:FairValueHYPEReceivedAsInkindContributions
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3342"
      unitRef="uref_1042948581">6673918</thyp:FairValueHYPEReceivedAsInkindContributions>
    <thyp:HYPERewardsReceived
      contextRef="cref_319941239"
      decimals="4"
      id="ixv-3343"
      unitRef="uref_1489602641">4938.2047</thyp:HYPERewardsReceived>
    <thyp:FairValueHYPERewardsReceived
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3344"
      unitRef="uref_1042948581">333391</thyp:FairValueHYPERewardsReceived>
    <thyp:QuantityOfHYPEHYPESoldForCashRedemptions
      contextRef="cref_319941239"
      decimals="4"
      id="ixv-3345"
      unitRef="uref_1489602641">-196947.0255</thyp:QuantityOfHYPEHYPESoldForCashRedemptions>
    <thyp:FairValueHYPESoldForCashRedemptions
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3346"
      unitRef="uref_1042948581">-13031236</thyp:FairValueHYPESoldForCashRedemptions>
    <thyp:QuantityOfHYPEHYPEDistributedForIn-KindRedemptions
      contextRef="cref_319941239"
      decimals="4"
      id="ixv-3347"
      unitRef="uref_1489602641">-28996.1452</thyp:QuantityOfHYPEHYPEDistributedForIn-KindRedemptions>
    <thyp:FairValueOfHYPEHYPEDistributedForIn-KindRedemptions
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3348"
      unitRef="uref_1042948581">-2446277</thyp:FairValueOfHYPEHYPEDistributedForIn-KindRedemptions>
    <thyp:QuantityOfHYPEHYPESoldToPayExpenses
      contextRef="cref_319941239"
      decimals="4"
      id="ixv-3349"
      unitRef="uref_1489602641">-1824.5998</thyp:QuantityOfHYPEHYPESoldToPayExpenses>
    <thyp:FairValueHYPESoldToPayExpenses
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3350"
      unitRef="uref_1042948581">-122461</thyp:FairValueHYPESoldToPayExpenses>
    <thyp:QuantityOfHYPEHYPESoldForDistributions
      contextRef="cref_319941239"
      decimals="4"
      id="ixv-3351"
      unitRef="uref_1489602641">-3850.48</thyp:QuantityOfHYPEHYPESoldForDistributions>
    <thyp:FairValueHYPESoldForDistributions
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3352"
      unitRef="uref_1042948581">-338707</thyp:FairValueHYPESoldForDistributions>
    <thyp:FairValueNetRealizedGainOnInvestmentInHYPESoldToPaySponsorFee
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3353"
      unitRef="uref_1042948581">15613</thyp:FairValueNetRealizedGainOnInvestmentInHYPESoldToPaySponsorFee>
    <thyp:FairValueNetRealizedGainOnInvestmentInHYPESoldForRedemptions
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3354"
      unitRef="uref_1042948581">2296556</thyp:FairValueNetRealizedGainOnInvestmentInHYPESoldForRedemptions>
    <thyp:FairValueOfHYPENetRealizedGainOnInvestmentInHYPEDistributedForIn-KindRedemotions
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3355"
      unitRef="uref_1042948581">1310590</thyp:FairValueOfHYPENetRealizedGainOnInvestmentInHYPEDistributedForIn-KindRedemotions>
    <thyp:FairValueNetRealizedGainOnInvestmentInHYPESoldForDistributions
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3356"
      unitRef="uref_1042948581">113007</thyp:FairValueNetRealizedGainOnInvestmentInHYPESoldForDistributions>
    <thyp:FairValueNetChangeInUnrealizedAppreciationOnInvestmentInHYPE
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3357"
      unitRef="uref_1042948581">18140784</thyp:FairValueNetChangeInUnrealizedAppreciationOnInvestmentInHYPE>
    <us-gaap:InvestmentOwnedBalanceContracts
      contextRef="cref_179931627"
      decimals="4"
      id="ixv-3358"
      unitRef="uref_1489602641">1023491.253</us-gaap:InvestmentOwnedBalanceContracts>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="cref_179931627"
      decimals="0"
      id="ixv-3359"
      unitRef="uref_1042948581">90783674</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock contextRef="cref_319941239" id="ixv-1859">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;" width="100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt; &lt;/td&gt;&lt;td style="width: 0.25in;"&gt;4.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Trust Expenses&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="margin-top: 0; margin-bottom: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; The Trust pays the unitary Sponsor Fee of 0.30% of the Trust&#x2019;s NAV (the &#x201c;Sponsor Fee&#x201d;). The Sponsor Fee is paid by the Trust to the Sponsor as compensation for services performed under the Trust Agreement. The Sponsor Fee accrues daily and is payable in HYPE at least quarterly in arrears. The Administrator calculates the Sponsor Fee on a daily basis by applying an annualized rate to the Trust&#x2019;s NAV, and the amount of HYPE payable in respect of each daily accrual is determined by reference to the Pricing Benchmark. The Sponsor has agreed to pay all operating expenses (except for litigation expenses and other extraordinary expenses) out of the Sponsor Fee. The Trust incurred a Sponsor Fee for the three months ended September 30, 2026 of $50,179. The accrued liability as of September 30, 2026 and June 30, 2026 was $2,004 and $2,736, respectively. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor has agreed to pay all operating expenses (except for litigation expenses, extraordinary expenses and taxes) out of the Sponsor Fee. Operating expenses assumed by the Sponsor include (i) the fee payable to the marketing agent for services it provides to the Trust (the &#x201c;Marketing Fee&#x201d;), (ii) fees to the Administrator, if any, (iii) fees to the HYPE Custodians, (iv) fees to the Transfer Agent, (v) fees to the Trustee, (vi) the fees and expenses related to any future listing, trading or quotation of the Shares on any listing exchange or quotation system (including legal, marketing and audit fees and expenses), (vii) ordinary course legal fees and expenses but not litigation-related expenses, (viii) audit fees, (ix) regulatory fees, including, if applicable, any fees relating to the registration of the Shares under the Securities Act, or the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), (x) printing and mailing costs, (xi) costs of maintaining the Sponsor&#x2019;s website and (xii) applicable license fees (each, a &#x201c;Sponsor-paid Expense,&#x201d; and together, the &#x201c;Sponsor-paid Expenses&#x201d;), provided that any expense that qualifies as an Additional Trust Expense will be deemed to be an Additional Trust Expense and not a Sponsor-paid Expense. There is currently no predetermined cap on the aggregate amount of Sponsor-paid expenses. Should the Trust implement a predetermined cap on aggregate Sponsor-paid expenses, the Trust will notify the owners of the beneficial interests of Shares in a prospectus supplement or in its periodic Exchange Act reports, as applicable.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; The Sponsor will not, however, assume certain extraordinary, non-recurring expenses that are not Sponsor-paid Expenses, including, but not limited to, taxes and governmental charges, expenses and costs of any extraordinary services performed by the Sponsor (or any other service provider) on behalf of the Trust to protect the Trust or the interests of Shareholders, any indemnification of the HYPE Custodians, Administrator or other agents, service providers or counter-parties of the Trust, the fees and expenses related to the initial listing of Shares on the Exchange, and extraordinary legal fees and expenses, including any legal fees and expenses incurred in connection with litigation, regulatory enforcement or investigation matters (collectively, &#x201c;Additional Trust Expenses&#x201d;). Of the Sponsor-paid Expenses, ordinary course legal fees and expenses shall be subject to a cap of $100,000 per annum. In the Sponsor&#x2019;s sole discretion, all or any portion of a Sponsor-paid Expense may be re-designated as an Additional Trust Expense if, among other reasons, the Sponsor determines that a Sponsor-paid Expense is an extraordinary, non-recurring expense of the Trust. The Trust shall not be responsible for paying any fees or expenses associated with the transfer of HYPE as needed to pay the Sponsor Fee or Additional Trust Expenses. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; In consideration for the Sponsor&#x2019;s facilitation of staking, the Trust pays a portion of the staking rewards generated by the Trust&#x2019;s Staking Activities after deduction of the Staking Provider Consideration to the Sponsor (&#x201c;Staking Fee&#x201d;). The Staking Fee is accrued in HYPE and converted to U.S. Dollars by reference to the Pricing Benchmark and is payable in HYPE at least quarterly in arrears. The Trust incurred Staking Fee for the three months ended September 30, 2026 of $65,247. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;To the extent that the Sponsor does not voluntarily assume expenses, they will be the responsibility of the Trust. The Sponsor also pays the costs of the Trust&#x2019;s organization and offering. The Trust is not obligated to repay any such costs related to the Trust&#x2019;s organization and offering paid by the Sponsor.&lt;/p&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <thyp:PercentageOfSponsorFee
      contextRef="cref_1938330277"
      decimals="4"
      id="ixv-3360"
      unitRef="uref_1489602641">0.003</thyp:PercentageOfSponsorFee>
    <us-gaap:SponsorFees
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3361"
      unitRef="uref_1042948581">50179</us-gaap:SponsorFees>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_179931627"
      decimals="0"
      id="ixv-3362"
      unitRef="uref_1042948581">2004</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_1474050272"
      decimals="0"
      id="ixv-3363"
      unitRef="uref_1042948581">2736</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LegalFees
      contextRef="cref_1938330277"
      decimals="0"
      id="ixv-3364"
      unitRef="uref_1042948581">100000</us-gaap:LegalFees>
    <thyp:StakingFee
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3365"
      unitRef="uref_1042948581">65247</thyp:StakingFee>
    <thyp:CreationAndRedemptionOfSharesTextBlock contextRef="cref_319941239" id="ixv-1885">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;" width="100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt; &lt;/td&gt;&lt;td style="width: 0.25in;"&gt;5.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Creation and Redemption of Shares&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="margin-top: 0; margin-bottom: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; The Trust creates and redeems Shares on a continuous basis but only in blocks consisting of 10,000 Shares (a &#x201c;Creation Basket&#x201d;) or multiples thereof at the NAV on the date of the creation or redemption. Only &#x201c;Authorized Participants&#x201d;, which are registered broker-dealers who have entered into written agreements with the Sponsor and the Administrator, can place orders. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Authorized Participants may purchase Shares in cash by depositing cash in the Trust&#x2019;s account with the Cash Custodian. This will cause the Sponsor, on behalf of the Trust, to automatically instruct a HYPE Counterparty to (i) purchase the amount of HYPE equivalent in value to the cash deposit amount associated with the order and (ii) deposit the resulting HYPE amount in the Trust&#x2019;s accounts with the HYPE Custodians, resulting in the Transfer Agent crediting the applicable amount of Shares to the Authorized Participant. Authorized Participants may also purchase Shares in-kind. To purchase Shares in-kind, an Authorized Participant delivers, or arranges for the delivery by the Authorized Participant&#x2019;s designee of, HYPE to the Trust&#x2019;s accounts with a HYPE Custodian in exchange for Shares.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;When such an Authorized Participant redeems its Shares in cash, the Sponsor, on behalf of the Trust, will direct a HYPE Custodian to transfer HYPE to a HYPE Counterparty, who will sell the HYPE to be executed, in the Sponsor&#x2019;s reasonable efforts, at the Pricing Benchmark price used to calculate the Trust&#x2019;s NAV, taking into account any spread, commissions, or other trading costs and deposit the cash proceeds of such sale in the Trust&#x2019;s account with the Cash Custodian for settlement with the Authorized Participant. Any slippage incurred (including, but not limited to, any trading fees, spreads, or commissions), on a cash equivalent basis, will be the responsibility of the Authorized Participant and not of the Trust or Sponsor. Authorized Participants may also redeem Shares in-kind. When such an Authorized Participant redeems Shares in-kind, the Trust, through a HYPE Custodian, will deliver HYPE to the Authorized Participant or its designee in exchange for Shares.&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months Ended September 30, &lt;br/&gt; 2026*&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;(Unaudited)&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold;"&gt;Activity in Capital Shares:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%;"&gt;Shares issued&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;280,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Shares redeemed&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(390,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Net Change in Capital Shares&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(110,000&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;*&lt;/td&gt; &lt;td style="text-align: justify;"&gt;No prior year comparative period presented as the Trust did not have any operations as of September 30, 2025.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months&lt;br/&gt; Ended&lt;br/&gt;  September&lt;br/&gt;     30, &lt;br/&gt; 2026*&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;(Unaudited)&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold;"&gt;Activity in Capital Transactions:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: left;"&gt;Contributions for Shares issued&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;13,334,689&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Distributions for Shares redeemed&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(15,477,513&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Net Change in Capital Transactions&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(2,142,824&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;*&lt;/td&gt; &lt;td style="text-align: justify;"&gt;No prior year comparative period presented as the Trust did not have any operations as of September 30, 2025.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt;       &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;HYPE purchased payable represents the quantity of HYPE purchased for the creation of Shares or Staking Rewards where the HYPE has not yet settled. Generally, HYPE is transferred within two Business Days of the trade date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;September 30,&lt;br/&gt; 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;June 30, &lt;br/&gt; 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;(Unaudited)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;HYPE purchased payable&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1003635765;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_911737347;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;HYPE sold receivable represents the quantity of HYPE sold for the redemption of Shares or Staking Rewards where the HYPE has not yet been settled. Generally, HYPE is transferred within two Business Days of the trade date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;September 30, &lt;br/&gt; 2026&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30, &lt;br/&gt; 2026&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;(Unaudited)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;HYPE sold receivable&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2105761333;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;3,010,519&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </thyp:CreationAndRedemptionOfSharesTextBlock>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="cref_1938330277"
      decimals="0"
      id="ixv-3366"
      unitRef="uref_1942895230">10000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="cref_319941239" id="ixv-1906">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months Ended September 30, &lt;br/&gt; 2026*&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;(Unaudited)&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold;"&gt;Activity in Capital Shares:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%;"&gt;Shares issued&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;280,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;Shares redeemed&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(390,000&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Net Change in Capital Shares&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(110,000&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;*&lt;/td&gt; &lt;td style="text-align: justify;"&gt;No prior year comparative period presented as the Trust did not have any operations as of September 30, 2025.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months&lt;br/&gt; Ended&lt;br/&gt;  September&lt;br/&gt;     30, &lt;br/&gt; 2026*&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;(Unaudited)&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-weight: bold;"&gt;Activity in Capital Transactions:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; text-align: left;"&gt;Contributions for Shares issued&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;13,334,689&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Distributions for Shares redeemed&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(15,477,513&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt;"&gt;Net Change in Capital Transactions&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;(2,142,824&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify;"&gt;&lt;td style="width: 0in;"&gt;&lt;/td&gt; &lt;td style="width: 0.25in; text-align: left;"&gt;*&lt;/td&gt; &lt;td style="text-align: justify;"&gt;No prior year comparative period presented as the Trust did not have any operations as of September 30, 2025.&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_319941239"
      decimals="0"
      id="fc_763897087"
      unitRef="uref_1942895230">280000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1230812605"
      unitRef="uref_1942895230">390000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
      contextRef="cref_319941239"
      decimals="0"
      id="fc_149445491"
      unitRef="uref_1942895230">-110000</us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1615734291"
      unitRef="uref_1042948581">13334689</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1515168913"
      unitRef="uref_1042948581">15477513</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:InvestmentCompanyIncreaseDecreaseFromShareTransaction
      contextRef="cref_319941239"
      decimals="0"
      id="fc_1766621886"
      unitRef="uref_1042948581">-2142824</us-gaap:InvestmentCompanyIncreaseDecreaseFromShareTransaction>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="cref_319941239" id="ixv-2005">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;HYPE purchased payable represents the quantity of HYPE purchased for the creation of Shares or Staking Rewards where the HYPE has not yet settled. Generally, HYPE is transferred within two Business Days of the trade date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;September 30,&lt;br/&gt; 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;June 30, &lt;br/&gt; 2026&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;(Unaudited)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;HYPE purchased payable&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_1003635765;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_911737347;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="cref_319941239" id="ixv-2051">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;HYPE sold receivable represents the quantity of HYPE sold for the redemption of Shares or Staking Rewards where the HYPE has not yet been settled. Generally, HYPE is transferred within two Business Days of the trade date.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="white-space: nowrap;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;September 30, &lt;br/&gt; 2026&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;June 30, &lt;br/&gt; 2026&lt;/td&gt; &lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: right;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;(Unaudited)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 76%; text-align: left;"&gt;HYPE sold receivable&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;&lt;span style="-sec-ix-hidden:fc_2105761333;"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right;"&gt;3,010,519&lt;/td&gt; &lt;td style="width: 1%; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ReceivableInvestmentSale
      contextRef="cref_1474050272"
      decimals="0"
      id="ixv-3374"
      unitRef="uref_1042948581">3010519</us-gaap:ReceivableInvestmentSale>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_319941239" id="ixv-2090">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;" width="100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt; &lt;/td&gt;&lt;td style="width: 0.25in;"&gt;6.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Related Parties&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="margin-top: 0; margin-bottom: 0;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor is a related party to the Trust. The Trust&#x2019;s operations are supported by its Sponsor, who is in turn supported by its parent company and affiliated companies and external service providers.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; On March 18, 2026, the Sponsor, in its capacity as the Seed Capital Investor, subject to conditions, purchased the Initial Seed Shares at a per-Share price of $50. Total proceeds to the Trust from the sale of the Initial Seed Shares were $100. Delivery of the Initial Seed Shares was made on March 18, 2026. These Initial Seed Shares were redeemed for cash on March 23, 2026. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; On May 11, 2026, the Sponsor, in its capacity as the Seed Capital Investor, subject to conditions, purchased Seed Creation Baskets at a per-Share price of $24.40. Total proceeds to the Trust from the sale of the Seed Creation Baskets were $488,079. Delivery of the Seed Creation Baskets was made on May 11, 2026. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; As of September 30, 2026 and June 30, 2026, the Sponsor owned 20,000 Shares of the Trust. &lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor arranged for the creation of the Trust and is responsible for the ongoing registration of the Shares for their public offering in the United States and the listing of Shares on the Exchange.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt; For the three months ended September 30, 2026, the Trust engaged in digital asset trading activity with FalconX Bravo, Inc. (&#x201c;FalconX Bravo&#x201d;), a registered swap dealer and a subsidiary of FalconX, which became an affiliated entity in November 2025, consisting of purchases in the amount of $2,248,428 and sales of $0. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_2032790478"
      decimals="0"
      id="ixv-3375"
      unitRef="uref_179931627">50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="cref_1432048928"
      decimals="0"
      id="fc_1432048928"
      unitRef="uref_1042948581">100</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_780255807"
      decimals="2"
      id="ixv-3377"
      unitRef="uref_179931627">24.4</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="cref_171125964"
      decimals="0"
      id="fc_171125964"
      unitRef="uref_1042948581">488079</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:CommonStockSharesHeldInEmployeeTrustShares
      contextRef="cref_1638411861"
      decimals="0"
      id="fc_1638411861"
      unitRef="uref_1942895230">20000</us-gaap:CommonStockSharesHeldInEmployeeTrustShares>
    <us-gaap:CommonStockSharesHeldInEmployeeTrustShares
      contextRef="cref_1942895230"
      decimals="0"
      id="ixv-3380"
      unitRef="uref_1942895230">20000</us-gaap:CommonStockSharesHeldInEmployeeTrustShares>
    <us-gaap:CryptoAssetPurchase
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3381"
      unitRef="uref_1042948581">2248428</us-gaap:CryptoAssetPurchase>
    <us-gaap:CryptoAssetSale
      contextRef="cref_319941239"
      decimals="0"
      id="ixv-3382"
      unitRef="uref_1042948581">0</us-gaap:CryptoAssetSale>
    <us-gaap:InvestmentCompanyFinancialHighlightsTextBlock contextRef="cref_319941239" id="ixv-2117">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;" width="100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt; &lt;/td&gt;&lt;td style="width: 0.25in;"&gt;7.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Financial Highlights&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-style: italic; border-bottom: Black 1.5pt solid;"&gt;Per Share Performance (for a Share outstanding throughout the periods presented)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months Ended September 30,&lt;br/&gt;  2026*&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;(Unaudited)&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; font-weight: bold; padding-bottom: 1.5pt;"&gt;Net asset value per Share, beginning of period&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right;"&gt;37.86&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Net investment income&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Net realized and change in unrealized gain (loss)&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;13.50&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in;"&gt;Net change in net assets from operations&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;13.62&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left;"&gt;Less distributions from:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Net investment income&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(0.19&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Total distributions&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(0.19&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Net asset value per Share, end of period&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;51.29&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;Total return, at net asset value&lt;sup&gt;(3)(5)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;35.99&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="font-weight: bold; text-decoration: underline; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;span style="text-decoration:underline"&gt;Ratio to average net assets&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Net investment income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1.19&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Gross expenses&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.63&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Net expenses&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.63&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align: top; width: 0.25in;"&gt;&lt;span style="font-size: 10pt;"&gt;*&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: bottom;"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;No comparative statement has been provided as the Trust did not have operations as of September 30, 2025.&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&lt;span style="font-size: 10pt;"&gt;(1)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 10pt;"&gt;Calculated using average Shares outstanding.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&lt;span style="font-size: 10pt;"&gt;(2)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;The amount shown for a Share outstanding throughout the period may not agree with the change in the aggregate gains and losses for the period because of the timing of sales and repurchases of the Trust&#x2019;s Shares in relation to fluctuating market values for the Trust.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&lt;span style="font-size: 10pt;"&gt;(3)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;Total return is calculated based on the change in value during the period and is not annualized. An individual Shareholder&#x2019;s return and ratios may vary from the above total returns and ratios based on the timing of capital contributions to and withdrawals from the Trust.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&lt;span style="font-size: 10pt;"&gt;(4)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 10pt;"&gt;Annualized.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&lt;span style="font-size: 10pt;"&gt;(5)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 10pt; padding-bottom: 0px; margin-bottom: 0px;"&gt;Not Annualized&lt;/span&gt;&lt;span style="font-size: 10pt; padding-top: 0px; margin-top: 0px;"&gt;.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;</us-gaap:InvestmentCompanyFinancialHighlightsTextBlock>
    <us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock contextRef="cref_319941239" id="ixv-2126">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif;"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="font-style: italic; border-bottom: Black 1.5pt solid;"&gt;Per Share Performance (for a Share outstanding throughout the periods presented)&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid;"&gt;Three Months Ended September 30,&lt;br/&gt;  2026*&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td style="text-align: center;"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center;"&gt;(Unaudited)&lt;/td&gt; &lt;td style="font-weight: bold;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom;"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="width: 88%; font-weight: bold; padding-bottom: 1.5pt;"&gt;Net asset value per Share, beginning of period&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right;"&gt;37.86&lt;/td&gt; &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; text-indent: -9pt; padding-left: 9pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Net investment income&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.12&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt;"&gt;&lt;span style="font-size: 10pt;"&gt;Net realized and change in unrealized gain (loss)&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;13.50&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in;"&gt;Net change in net assets from operations&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;13.62&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="text-align: left;"&gt;Less distributions from:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt;"&gt;Net investment income&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(0.19&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left; padding-bottom: 1.5pt;"&gt;Total distributions&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right;"&gt;(0.19&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left;"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; padding-bottom: 2.5pt;"&gt;Net asset value per Share, end of period&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt;"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: left;"&gt;$&lt;/td&gt; &lt;td style="border-bottom: Black 4pt double; text-align: right;"&gt;51.29&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="font-weight: bold; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;Total return, at net asset value&lt;sup&gt;(3)(5)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;35.99&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt;&lt;td style="font-weight: bold; text-decoration: underline; text-align: left;"&gt;&lt;span style="font-size: 10pt;"&gt;&lt;span style="font-weight: bold;"&gt;&lt;span style="text-decoration:underline"&gt;Ratio to average net assets&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Net investment income&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;1.19&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White;"&gt; &lt;td style="text-align: left;"&gt;Gross expenses&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.63&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255);"&gt; &lt;td style="text-align: left;"&gt;Net expenses&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left;"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right;"&gt;0.63&lt;/td&gt; &lt;td style="text-align: left;"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse;"&gt; &lt;tbody&gt;&lt;tr&gt;&lt;td style="vertical-align: top; width: 0.25in;"&gt;&lt;span style="font-size: 10pt;"&gt;*&lt;/span&gt;&lt;/td&gt; &lt;td style="vertical-align: bottom;"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"&gt;No comparative statement has been provided as the Trust did not have operations as of September 30, 2025.&lt;/p&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&lt;span style="font-size: 10pt;"&gt;(1)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 10pt;"&gt;Calculated using average Shares outstanding.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&lt;span style="font-size: 10pt;"&gt;(2)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;The amount shown for a Share outstanding throughout the period may not agree with the change in the aggregate gains and losses for the period because of the timing of sales and repurchases of the Trust&#x2019;s Shares in relation to fluctuating market values for the Trust.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&lt;span style="font-size: 10pt;"&gt;(3)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="font-size: 10pt;"&gt;Total return is calculated based on the change in value during the period and is not annualized. An individual Shareholder&#x2019;s return and ratios may vary from the above total returns and ratios based on the timing of capital contributions to and withdrawals from the Trust.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&lt;span style="font-size: 10pt;"&gt;(4)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 10pt;"&gt;Annualized.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td&gt;&lt;span style="font-size: 10pt;"&gt;(5)&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 10pt; padding-bottom: 0px; margin-bottom: 0px;"&gt;Not Annualized&lt;/span&gt;&lt;span style="font-size: 10pt; padding-top: 0px; margin-top: 0px;"&gt;.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;</us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock>
    <us-gaap:NetAssetValuePerShare
      contextRef="cref_1474050272"
      decimals="2"
      id="fc_1474050272"
      unitRef="uref_179931627">37.86</us-gaap:NetAssetValuePerShare>
    <thyp:NetInvestmentIncomeValuePerShare
      contextRef="cref_319941239"
      decimals="2"
      id="fc_6998217"
      unitRef="uref_179931627">0.12</thyp:NetInvestmentIncomeValuePerShare>
    <thyp:NetRealizedAndChangeInUnrealizedGainValuePerShare
      contextRef="cref_319941239"
      decimals="2"
      id="fc_440978387"
      unitRef="uref_179931627">13.5</thyp:NetRealizedAndChangeInUnrealizedGainValuePerShare>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
      contextRef="cref_319941239"
      decimals="2"
      id="fc_1235938110"
      unitRef="uref_179931627">13.62</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <thyp:DistributionsFromNetInvestmentIncome
      contextRef="cref_319941239"
      decimals="2"
      id="fc_1002523820"
      unitRef="uref_179931627">-0.19</thyp:DistributionsFromNetInvestmentIncome>
    <thyp:DistributionsNet
      contextRef="cref_319941239"
      decimals="2"
      id="fc_445689873"
      unitRef="uref_179931627">-0.19</thyp:DistributionsNet>
    <us-gaap:NetAssetValuePerShare
      contextRef="cref_179931627"
      decimals="2"
      id="fc_179931627"
      unitRef="uref_179931627">51.29</us-gaap:NetAssetValuePerShare>
    <us-gaap:InvestmentCompanyTotalReturnMarketValue
      contextRef="cref_319941239"
      decimals="4"
      id="fc_1865728665"
      unitRef="uref_1489602641">0.3599</us-gaap:InvestmentCompanyTotalReturnMarketValue>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio
      contextRef="cref_319941239"
      decimals="4"
      id="fc_1806713784"
      unitRef="uref_1489602641">0.0119</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:InvestmentCompanyExpenseRatioExcludingIncentiveFee
      contextRef="cref_319941239"
      decimals="4"
      id="fc_987271132"
      unitRef="uref_1489602641">0.0063</us-gaap:InvestmentCompanyExpenseRatioExcludingIncentiveFee>
    <us-gaap:InvestmentCompanyTotalReturn
      contextRef="cref_319941239"
      decimals="4"
      id="fc_1489602641"
      unitRef="uref_1489602641">0.0063</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_319941239" id="ixv-2294">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;" width="100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt; &lt;/td&gt;&lt;td style="width: 0.25in;"&gt;8.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Commitments and Contingent Liabilities&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;In the normal course of business, the Trust may enter into contracts that contain a variety of general indemnification clauses. The Trust&#x2019;s maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Trust which have not yet occurred and cannot be predicted with any certainty. However, the Sponsor believes the risk of loss under these arrangements to be remote.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="cref_319941239" id="ixv-2311">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;" width="100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt; &lt;/td&gt;&lt;td style="width: 0.25in;"&gt;9.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Concentration Risk&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;Unlike other funds that may invest in diversified assets, the Trust&#x2019;s investment strategy is concentrated in a single asset within a single asset class. This concentration maximizes the degree of the Trust&#x2019;s exposure to a variety of market risks associated with HYPE and digital assets. By concentrating its investment strategy solely in HYPE, any losses suffered as a result of a decrease in the value of HYPE can be expected to reduce the value of an interest in the Trust and will not be offset by other gains if the Trust were to invest in underlying assets that were diversified.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <thyp:IndemnificationTextBlock contextRef="cref_319941239" id="ixv-2322">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;" width="100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt; &lt;/td&gt;&lt;td style="width: 0.25in;"&gt;10.&lt;/td&gt; &lt;td&gt;&lt;span style="text-decoration:underline"&gt;Indemnification&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor will not be liable to the Trust, the Trustee or any Shareholder for any action taken or for refraining from taking any action in good faith, or for errors in judgment or for depreciation or loss incurred by reason of the sale of any HYPE or other assets of the Trust. However, the preceding liability exclusion will not protect the Sponsor against any liability resulting from its own gross negligence, bad faith, or willful misconduct.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Sponsor and each of its Shareholders, members, directors, officers, employees, affiliates, and subsidiaries will be indemnified by the Trust and held harmless against any losses, liabilities or expenses incurred in the performance of its duties under the Trust Agreement without gross negligence, bad faith, or willful misconduct. The Sponsor may rely in good faith on any paper, order, notice, list, affidavit, receipt, evaluation, opinion, endorsement, assignment, draft, or any other document of any kind prima facie properly executed and submitted to it by the Trustee, the Trustee&#x2019;s counsel or by any other person for any matters arising under the Trust Agreement. The Sponsor shall in no event be deemed to have assumed or incurred any liability, duty, or obligation to any Shareholder or to the Trustee other than as expressly provided for in the Trust Agreement. Such indemnity includes payment from the Trust of the costs and expenses incurred in defending against any indemnified claim or liability under the Trust Agreement.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trustee will not be liable or accountable to the Trust or any other person or under any agreement to which the Trust or any series of the Trust is a party, except for the Trustee&#x2019;s breach of its obligations pursuant to the Trust Agreement or its own willful misconduct, bad faith or gross negligence. The Trustee and each of the Trustee&#x2019;s officers, affiliates, directors, employees, and agents will be indemnified by the Trust from and against any losses, claims, taxes, damages, reasonable expenses, and liabilities incurred with respect to the creation, operation or termination of the Trust, the execution, delivery or performance of the Trust Agreement or the transactions contemplated thereby; provided that the indemnified party acted without willful misconduct, bad faith or gross negligence.&lt;/p&gt;</thyp:IndemnificationTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_319941239" id="ixv-2337">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;" width="100%"&gt;&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;&lt;td style="width: 0.25in;"&gt; &lt;/td&gt;&lt;td style="width: 0.25in;"&gt;11.&lt;/td&gt; &lt;td style="text-align: justify;"&gt;&lt;span style="text-decoration:underline"&gt;Subsequent Events&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in;"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in;"&gt;The Trust has evaluated all subsequent events and transactions for potential recognition or disclosure through the issuance of the financial statements and has noted no events requiring adjustment or additional disclosure in the financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_319941239" id="ixv-3399">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_319941239" id="ixv-3400">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_319941239" id="ixv-3401">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_319941239" id="ixv-3402">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_1865728665"
          xlink:label="fc_1865728665"
          xlink:type="locator"/>
        <link:footnote id="fref_1723762184" xlink:label="fref_1723762184" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Not Annualized.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1865728665"
          xlink:to="fref_1723762184"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1526000497"
          xlink:label="fc_1526000497"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1765843386"
          xlink:label="fc_1765843386"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_789196709"
          xlink:label="fc_789196709"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_437559600"
          xlink:label="fc_437559600"
          xlink:type="locator"/>
        <link:footnote id="fref_208768319" xlink:label="fref_208768319" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">85.92% of HYPE held was staked as of September 30, 2026 &#x2013; See Note 2</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1526000497"
          xlink:to="fref_208768319"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1765843386"
          xlink:to="fref_208768319"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_789196709"
          xlink:to="fref_208768319"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_437559600"
          xlink:to="fref_208768319"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1893996833"
          xlink:label="fc_1893996833"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_813332056"
          xlink:label="fc_813332056"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_533837556"
          xlink:label="fc_533837556"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_865381281"
          xlink:label="fc_865381281"
          xlink:type="locator"/>
        <link:footnote id="fref_1440550292" xlink:label="fref_1440550292" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">94.43% of HYPE held was staked as of June 30, 2026 &#x2013; See Note 2.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1893996833"
          xlink:to="fref_1440550292"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_813332056"
          xlink:to="fref_1440550292"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_533837556"
          xlink:to="fref_1440550292"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_865381281"
          xlink:to="fref_1440550292"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1728963019"
          xlink:label="fc_1728963019"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1638172232"
          xlink:label="fc_1638172232"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_491529723"
          xlink:label="fc_491529723"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_144611834"
          xlink:label="fc_144611834"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1898376236"
          xlink:label="fc_1898376236"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1528281662"
          xlink:label="fc_1528281662"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_627146256"
          xlink:label="fc_627146256"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_36202461"
          xlink:label="fc_36202461"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_507978301"
          xlink:label="fc_507978301"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_2090963384"
          xlink:label="fc_2090963384"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1715314990"
          xlink:label="fc_1715314990"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1069639915"
          xlink:label="fc_1069639915"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1220959562"
          xlink:label="fc_1220959562"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_300858975"
          xlink:label="fc_300858975"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_425164440"
          xlink:label="fc_425164440"
          xlink:type="locator"/>
        <link:footnote id="fref_1766460165" xlink:label="fref_1766460165" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No comparative statement has been provided as the Trust did not have operations as of September 30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1728963019"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1638172232"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_491529723"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_144611834"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1898376236"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1528281662"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_627146256"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_36202461"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_507978301"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2090963384"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1715314990"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1069639915"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1220959562"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_300858975"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_425164440"
          xlink:to="fref_1766460165"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1708398178"
          xlink:label="fc_1708398178"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_877473242"
          xlink:label="fc_877473242"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_395078499"
          xlink:label="fc_395078499"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_993781903"
          xlink:label="fc_993781903"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_975365104"
          xlink:label="fc_975365104"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1214535169"
          xlink:label="fc_1214535169"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1023294057"
          xlink:label="fc_1023294057"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1641535774"
          xlink:label="fc_1641535774"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1943067888"
          xlink:label="fc_1943067888"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1758181250"
          xlink:label="fc_1758181250"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_488197162"
          xlink:label="fc_488197162"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1819430525"
          xlink:label="fc_1819430525"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1854229798"
          xlink:label="fc_1854229798"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_886546308"
          xlink:label="fc_886546308"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_2855794"
          xlink:label="fc_2855794"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_173996789"
          xlink:label="fc_173996789"
          xlink:type="locator"/>
        <link:footnote id="fref_1652039340" xlink:label="fref_1652039340" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No comparative statement has been provided as the Trust did not have operations as of September 30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1708398178"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_877473242"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_395078499"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_993781903"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_975365104"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1214535169"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1023294057"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1641535774"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1943067888"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1758181250"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_488197162"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1819430525"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1854229798"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_886546308"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2855794"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_173996789"
          xlink:to="fref_1652039340"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1766621886"
          xlink:label="fc_1766621886"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1515168913"
          xlink:label="fc_1515168913"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_149445491"
          xlink:label="fc_149445491"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1615734291"
          xlink:label="fc_1615734291"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1230812605"
          xlink:label="fc_1230812605"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_763897087"
          xlink:label="fc_763897087"
          xlink:type="locator"/>
        <link:footnote id="fref_1989728582" xlink:label="fref_1989728582" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No prior year comparative period presented as the Trust did not have any operations as of September 30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1766621886"
          xlink:to="fref_1989728582"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1515168913"
          xlink:to="fref_1989728582"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_149445491"
          xlink:to="fref_1989728582"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1615734291"
          xlink:to="fref_1989728582"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1230812605"
          xlink:to="fref_1989728582"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_763897087"
          xlink:to="fref_1989728582"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_6998217"
          xlink:label="fc_6998217"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1474050272"
          xlink:label="fc_1474050272"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1235938110"
          xlink:label="fc_1235938110"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_440978387"
          xlink:label="fc_440978387"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1806713784"
          xlink:label="fc_1806713784"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_445689873"
          xlink:label="fc_445689873"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_987271132"
          xlink:label="fc_987271132"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1002523820"
          xlink:label="fc_1002523820"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_179931627"
          xlink:label="fc_179931627"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1489602641"
          xlink:label="fc_1489602641"
          xlink:type="locator"/>
        <link:footnote id="fref_371514832" xlink:label="fref_371514832" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No comparative statement has been provided as the Trust did not have operations as of September 30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_6998217"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1474050272"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1865728665"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1235938110"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_440978387"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1806713784"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_445689873"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_987271132"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1002523820"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_179931627"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1489602641"
          xlink:to="fref_371514832"
          xlink:type="arc"/>
        <link:footnote id="fref_511225812" xlink:label="fref_511225812" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Calculated using average Shares outstanding.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_6998217"
          xlink:to="fref_511225812"
          xlink:type="arc"/>
        <link:footnote id="fref_1131480676" xlink:label="fref_1131480676" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amount shown for a Share outstanding throughout the period may not agree with the change in the aggregate gains and losses for the period because of the timing of sales and repurchases of the Trust&#x2019;s Shares in relation to fluctuating market values for the Trust.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_440978387"
          xlink:to="fref_1131480676"
          xlink:type="arc"/>
        <link:footnote id="fref_565327056" xlink:label="fref_565327056" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Total return is calculated based on the change in value during the period and is not annualized. An individual Shareholder&#x2019;s return and ratios may vary from the above total returns and ratios based on the timing of capital contributions to and withdrawals from the Trust.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1865728665"
          xlink:to="fref_565327056"
          xlink:type="arc"/>
        <link:footnote id="fref_1661752728" xlink:label="fref_1661752728" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Annualized.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1806713784"
          xlink:to="fref_1661752728"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_987271132"
          xlink:to="fref_1661752728"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1489602641"
          xlink:to="fref_1661752728"
          xlink:type="arc"/>
        <link:footnote id="fref_1122317388" xlink:label="fref_1122317388" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-size: 10pt; padding-bottom: 0px; margin-bottom: 0px;">Not Annualized</xhtml:span><xhtml:span style="font-size: 10pt; padding-top: 0px; margin-top: 0px;">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1865728665"
          xlink:to="fref_1122317388"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
